The promotion of mitochondrial oxidative stress associated with the deletion/inhibition of NOX4 in hepatocytes diminished insulin signaling, whereas NOX4 deficiency in vivo promoted hepatic and systemic insulin resistance, a key driver of NAFLD. The gene discussed is INS; the disease is Insulin resistance.